Guideline Implementation for Breast Healthcare in Low- and Middle-Income Countries Breast Healthcare Program Resource Allocation
Guideline Implementation for Breast Healthcare in Low- and Middle-Income Countries Breast Healthcare Program Resource Allocation
复制标题
DOI:
10.1002/cncr.23841
复制
发表时间:
2008-10-15
期刊:
影响因子:
6.2
通讯作者:
Fischietto, Mary
中科院分区:
文献类型:
--
作者:
Harford, Joe;Azavedo, Edward;Fischietto, Mary
Breast cancer is serious public health problem ill countries of all resource levels. Although major advances in the detection art treatment of the disease have Occurred in higher income settings, similar progress has been slow or scarce in most low- and middle-income countries (LMCs). The poorer outcomes in LMCs may relate to the limited capability of their healthcare systems (HCS) to provide successful early detection, diagnosis, and treatment of breast cancer. Impediments to bettei outcomes include insufficient numbers of appropriately trained healthcare workers, limited access to SCFeeniog/treatioerit facilities, inadequate supplies of occessary drugs, timeliness of treatment after diagnosis. Clearly these HCS deficiencies are broader than the scope of the Breast Health Global Initiative (BHGI) and are not unique to the issue of breast cancer. To address issues ill FICS that hinder the delivery Of breast health services, the BHGI Healthcare Systems and Public policy Panel explored HCS structures and Function needed to operate a breast care program (BCP). Like with all BHGI guidelines, those proposed by this planel were expressed in terms of' 4 strata of resource levels: basic, limited, enhanced, and maximal. The current report describes the issues and questions related to FICS that are important to consider when designing, implementing, and measuring the performance of' a BCP Health ministers, other policymakers. healthcare personnel, adimnistrators,arld anyooe else involved in developing it BCP Call Use and adapt this frame work to improve outcomes arld ensure the more effective Use of resources. Cancer 2008;113(8 suppl):2282-96. (C) 2008 American Cancer Society